IL12A and pulmonary arterial hypertension: Furthermore, iPSC-based therapy reduced the expression of the inflammatory markers CD68, MHC-II, IL-1β, IL-6, IL-12α, IL-12β, IL-23 and IFNγ in a rat PAH model.